Literature DB >> 10342887

Identification of vitronectin as a novel insulin-like growth factor-II binding protein.

Z Upton1, H Webb, K Hale, C A Yandell, J P McMurtry, G L Francis, F J Ballard.   

Abstract

We have previously reported the presence of a 70 kDa insulin-like growth factor (IGF)-II-specific binding protein in chicken serum using Western ligand blotting approaches. In order to ascertain the identity of this 70 kDa IGF-II binding species, the protein has been purified from chicken serum using a combination of ion-exchange and gel-permeation chromatography. Interestingly, amino acid sequencing of the purified protein revealed that it has the same N-terminal sequence as chicken vitronectin (VN). The protein has the ability to specifically bind IGF-II and not IGF-I as determined by ligand blotting, cross-linking and competitive binding assay approaches. In addition, the protein binds 125I-des(1-6)-IGF-II, suggesting that the interaction with IGF-II is different to those with other characterized IGF-binding proteins. Importantly, we have ascertained that both human and bovine VN also specifically bind IGF-II. These results are particularly relevant in the light of the recent report that the urokinase-type plasminogen activator receptor, a protein that also binds VN, has been shown to associate with the cation-independent mannose-6-phosphate/IGF-II receptor and suggest a possible role for IGF-II in cell adhesion and invasion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10342887     DOI: 10.1210/endo.140.6.6929

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Vitronectin accumulates in the interstitium but minimally impacts fibrogenesis in experimental chronic kidney disease.

Authors:  Jesús M López-Guisa; Allen C Rassa; Xiaohe Cai; Sarah J Collins; Allison A Eddy
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-26

Review 2.  Complement activation in the context of stem cells and tissue repair.

Authors:  Ingrid U Schraufstatter; Sophia K Khaldoyanidi; Richard G DiScipio
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

3.  Provisional Matrix Deposition in Hemostasis and Venous Insufficiency: Tissue Preconditioning for Nonhealing Venous Ulcers.

Authors:  Tony J Parker; James A Broadbent; Jacqui A McGovern; Daniel A Broszczak; Christina N Parker; Zee Upton
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

4.  Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: a role for osteopontin.

Authors:  Akira Hirata; Satoru Masuda; Tetsuo Tamura; Kazuko Kai; Koichi Ojima; Akiko Fukase; Kazuo Motoyoshi; Keiko Kamakura; Yuko Miyagoe-Suzuki; Shin'ichi Takeda
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

5.  Effect of vitronectin bound to insulin-like growth factor-I and insulin-like growth factor binding protein-3 on porcine enamel organ-derived epithelial cells.

Authors:  Yoshinori Shinohara; Shuhei Tsuchiya; Kazuo Hatae; Masaki J Honda
Journal:  Int J Dent       Date:  2012-04-10

6.  Inhibition of insulin-like growth factor II (IGF-II)-dependent cell growth by multidentate pentamannosyl 6-phosphate-based ligands targeting the mannose 6-phosphate/IGF-II receptor.

Authors:  Megan E Zavorka; Christopher M Connelly; Rosslyn Grosely; Richard G MacDonald
Journal:  Oncotarget       Date:  2016-09-20

7.  PEDL: extracting protein-protein associations using deep language models and distant supervision.

Authors:  Leon Weber; Kirsten Thobe; Oscar Arturo Migueles Lozano; Jana Wolf; Ulf Leser
Journal:  Bioinformatics       Date:  2020-07-01       Impact factor: 6.937

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.